𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Breast cancer in a trans-sexual man receiving hormone replacement therapy

✍ Scribed by Mr I. Ganly; E. W. Taylor

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
95 KB
Volume
82
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of cancer in women receiving hormon
Risk of cancer in women receiving hormone replacement therapy
✍ Hans-Olov Adami; Ingemar Persson; Robert Hoover; Catharine Schairer; Leif Bergkv 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 828 KB

Cancer risk following treatment with non-contraceptive estrogens was studied in a population-based cohort of 23,244 women. Complete follow-up for an average of 6.7 years revealed 1,087 incident cancers versus 962.5 expected (relative risk/RR/ = 1.13; 95% confidence interval 1.10-1.20). We confirmed

Hormone replacement therapy and lung can
Hormone replacement therapy and lung cancer risk in Chinese
✍ Kuan-Yu Chen; Chin-Fu Hsiao; Gee-Chen Chang; Yin-Huang Tsai; Wu-Chou Su; Reury-P 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

## Abstract ## BACKGROUND. The association between hormone replacement therapy (HRT) and a reduced lung cancer risk has been reported in previous studies. There is a high female to male ratio in Chinese lung cancer patients, and female patients have different clinicopathological characteristics co

Cavernous hemangioma of the breast: Mamm
Cavernous hemangioma of the breast: Mammographic and sonographic findings and follow-up in a patient receiving hormone-replacement therapy
✍ Benoît Mesurolle; Marvin Wexler; Fawaz Halwani; Ann Aldis; Anna Veksler; Ellen K 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

## Abstract We report the case of a 78‐year‐old woman who had been receiving hormone‐replacement therapy (HRT) for 6 years and had a 4‐month history of a painless nodule in the 9 o'clock position in her right breast. Mammography performed 4 years previously had shown a 4‐mm bilobed, ovoid, well‐def

Hormone replacement therapy and breast c
Hormone replacement therapy and breast cancer in former users of oral contraceptives—The Norwegian Women and Cancer study
✍ Eiliv Lund; Kjersti Bakken; Vanessa Dumeaux; Vegard Andersen; Merethe Kumle 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 66 KB 👁 2 views

## Abstract Combined estrogen–progestin menopausal therapy (HRT) and combined estrogen–progestin contraceptives (OC) both increase breast cancer risk during current use and a few years after. We investigated risk of breast cancer in women who were users of HRT dependant on former history of OC use

Increased risk of breast cancer followin
Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe
✍ Claudia Stahlberg; Anette Tønnes Pedersen; Elsebeth Lynge; Zorana Jovanovic Ande 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 87 KB 👁 2 views

## Abstract Epidemiologic studies have shown an increased risk of breast cancer following hormone replacement therapy (HRT). The aim of this study was to investigate whether different treatment regimens or the androgenecity of progestins influence the risk of breast cancer differently. The Danish N